CEIP Fray Alonso Fernández from the small town of Malpartida de Plasencia (Cáceres), together with the center’s AMPA, has promoted a solidarity activity to contribute to the study of GRINpathies. The educational center organized a “solidarity sandwich” in order to raise funds for research against these diseases, a task carried out in the IDIBELL by […]
New solidarity drive to investigate GRINpathies Read More »
The International Agency for Research on Cancer (IARC) has published volume 17 of its Handbooks of Cancer Prevention collection, which focuses on the screening of colorectal cancer. The issue has been written by a workgroup of 23 independent experts from 15 countries appointed by the Agency, including Dr. Montse García, IDIBELL-ICO researcher of the Cancer
Last Saturday, May 25th, Negreira, a small town located in Galicia, held the 4th edition of its charity Triathlon. As in previous editions, funds raised by the organization will be entirely devoted to the study of rare diseases. This year, the organization decided to award 50% of the funds to the IDIBELL research group led
The solidarity of Negreira boosts GRINpathies research at IDIBELL Read More »
This re-accreditation complements the one obtained from CERCA at the beginning of the year
The IDIBELL and Bellvitge University Hospital researcher Joan Sabater, in collaboration with the Loop Dx start-up, of the Center for the Integration of Medicine and Innovative Technologies (CIMTI), has obtained € 100,000 of funding from the aid Product of the AGAUR agency of the Government of Catalonia. These aids are used to obtain prototypes and
SeptiLoop receives € 100,000 to develop a rapid diagnostic kit for sepsis Read More »
The Bellvitge Biomedical Research Institute (IDIBELL) would like to state that, in accordance with the new responsibility of Dr Manel Esteller as director of the Josep Carreras Leukaemia Research Institute (IJC), the Cancer Epigenetics and Biology Program (PEBC) that he has led at IDIBELL so far has been discontinued. IDIBELL research groups led by Dr Montserrat Sanchez-Cespedes, Dr Àlex Vaquero,
[Statement] Finalisation of IDIBELL’s Epigenetics and Cancer Biology Program Read More »
The Bellvitge Biomedical Research Institute commemorates its 15 years of existence evaluating its past and facing the future with optimism
IDIBELL celebrates 15 years Read More »
The researcher Raúl Zamora Ros, from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO), has been chosen by the jury of the Jesús Serra Foundation Research Awards as the winner in the clinical research category. This award is aimed at scientists below 45 years old specialized in nutrition, food and
Raúl Zamora wins the 2nd edition of the Jesús Serra Foundation Research Awards Read More »
A team of scientists led by Dr. Antonella Consiglio from the IDIBELL and the University of Barcelona (UB), and Dr. Angel Raya from the Center of Regenerative Medicine of Barcelona (CMR[B]/IDIBELL) reveal in Scientific Reports today an efficient and new method for generating fluorescently-labeled dopaminergic neurons (DAn), a specific cell type that die in Parkinson’s
Fluorescent dopaminergic neurons to accelerate Parkinson’s disease research Read More »
